Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo (Q46018739)
Jump to navigation
Jump to search
scientific article published on 8 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo |
scientific article published on 8 May 2009 |
Statements
1 reference
Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo (English)
1 reference
Janusz Rolski
1 reference
Steven M Grunberg
1 reference
Janos Strausz
1 reference
Zeba Aziz
1 reference
Stephen Lane
1 reference
Mark W Russo
1 reference
Paul Wissel
1 reference
Mary Guckert
1 reference
Oliver Wright
1 reference
Jørn Herrstedt
1 reference
8 May 2009
1 reference
1 reference
10
1 reference
6
1 reference
549-558
1 reference
Identifiers
1 reference
1 reference